LEXISCAN is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Astellas Pharma Us, Inc.. The primary component is Regadenoson.
| Product ID | 0469-6501_8fb5b92b-3654-43ff-98d3-3ac23c9a0b10 | 
| NDC | 0469-6501 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | LEXISCAN | 
| Generic Name | Regadenoson | 
| Dosage Form | Injection, Solution | 
| Route of Administration | INTRAVENOUS | 
| Marketing Start Date | 2008-04-10 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA022161 | 
| Labeler Name | Astellas Pharma US, Inc. | 
| Substance Name | REGADENOSON | 
| Active Ingredient Strength | 0 mg/mL | 
| Pharm Classes | Adenosine Receptor Agonist [EPC],Adenosine Receptor Agonists [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2020-12-31 | 
| Marketing Start Date | 2008-04-10 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA022161 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2008-04-10 | 
| Marketing End Date | 2011-10-20 | 
| Marketing Category | NDA | 
| Application Number | NDA022161 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | ML | 
| Marketing Start Date | 2008-04-10 | 
| Ingredient | Strength | 
|---|---|
| REGADENOSON | .08 mg/mL | 
| SPL SET ID: | 057289f4-2e18-4c1e-bed4-6c1858e2ef16 | 
| Manufacturer | |
| UNII | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0469-6501 | LEXISCAN | regadenoson | 
| 55150-443 | regadenoson | regadenoson | 
| 68083-175 | Regadenoson | Regadenoson | 
| 71288-201 | Regadenoson | Regadenoson | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  LEXISCAN  78890527  3503116 Live/Registered | Astellas US LLC 2006-05-23 |